...
机译:C-Met的高表达,PKC Lambda和Aldh1a3预测晚期乳腺癌预后差
Tokyo Univ Sci Fac Pharmaceut Sci Chiba Japan;
Tokyo Univ Sci Fac Pharmaceut Sci Chiba Japan;
Tokyo Univ Sci Fac Pharmaceut Sci Chiba Japan;
Tokyo Univ Sci Fac Pharmaceut Sci Chiba Japan;
Tokyo Univ Sci Fac Pharmaceut Sci Chiba Japan;
Tokyo Univ Sci Fac Pharmaceut Sci Chiba Japan;
Tokyo Univ Sci Fac Pharmaceut Sci Chiba Japan;
Tokyo Univ Sci Fac Pharmaceut Sci Chiba Japan;
Tokyo Univ Sci Res Inst Biomed Sci Chiba Japan;
Tokyo Univ Sci Fac Pharmaceut Sci Chiba Japan;
Tokyo Univ Sci Fac Pharmaceut Sci Chiba Japan;
Tokyo Univ Sci Fac Pharmaceut Sci Chiba Japan;
Tokyo Univ Sci Fac Pharmaceut Sci Chiba Japan;
Tokyo Univ Sci Fac Pharmaceut Sci Chiba Japan;
Tokyo Univ Sci Fac Pharmaceut Sci Chiba Japan;
Tokyo Univ Sci Res Inst Sci &
Technol Translat Res Ctr Chiba Japan;
Tokyo Univ Sci Fac Pharmaceut Sci Chiba Japan;
Cancer stem cell; breast cancer; ALDH1A3; c-Met; PKC lambda;
机译:C-Met的高表达,PKC Lambda和Aldh1a3预测晚期乳腺癌预后差
机译:PKCa低表达和KRAS高表达预示大肠癌患者预后不良
机译:DEPDC1的高表达促进乳腺癌细胞的恶性表型,并预测乳腺癌患者的预后不良。
机译:集成深度神经网络和支持向量机的人类乳腺癌预后预测:乳腺癌预后预测的有监督特征提取和分类
机译:1,25(OH)2D3和17-β雌二醇在体外对MCF-7乳腺癌和MCF10-A正常细胞PKCδ和PKCε表达的影响。
机译:PKCα低表达和KRAS高表达预示大肠癌患者预后不良
机译:C-met,pkcλ和Aldh1a3的高表达预测晚期乳腺癌预后差